Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review

Severe Erosive Pill Esophagitis Induced by Crizotinib Therapy: A Case Report and Literature Review

Previous case reports have described esophagitis thought to be secondary to crizotinib, an oral tyrosine-kinase inhibitor used in the treatment of anaplastic lymphoma kinase- (ALK-) positive non-small cell lung cancer (NSCLC). In those reports, the interval development of esophagitis was between two...

Full description

Bibliographic Details
Main Authors: Patrick Jung, Kyle J. Fortinsky, Zane R. Gallinger, Piero Tartaro
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Case Reports in Gastrointestinal Medicine
Online Access:http://dx.doi.org/10.1155/2016/3562820

Similar Items

Similar Items